Katie McWilliams, DO
Emergency Medicine · Hays, KSNPI 1568753820
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$154
- Sunovion Pharmaceuticals Inc.$150
- Sanofi-aventis U.S. LLC$126
- Novo Nordisk$71
- AbbVie$69
- AstraZeneca$59
- plus $409 from 15 others
What the payments were for
- Food & beverage$1,038100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $154 |
| Sunovion Pharmaceuticals Inc. | 14 | $150 |
| Sanofi-aventis U.S. LLC | 9 | $126 |
| Novo Nordisk | 5 | $71 |
| AbbVie | 4 | $69 |
| AstraZeneca | 5 | $59 |
| Organogenesis Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Novartis | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Lilly USA, LLC | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $33 |
| Boston Scientific | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Bayer | 1 | $11 |
How this compares
$1,038 in reported general payments places this provider in the 95th percentile of 334 emergency medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spironolactone | 11 | $315 |
| Ondansetron OdtOndansetron | 16 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $88 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Hays
- Nathan SmithHays$1K
- Marshall EidenbergHays$997
- Joseph WaeckerleOverland Park$266K
- Nima SaraniKansas City$65K
- Nicholas HoseyKansas City$56K
- Chad CannonKansas City$23K
- Roger TrotterDodge City$6K
- Andrew PirotteKansas City$2K
- Thomas KreamerOverland Park$2K
- Martha FanningOverland Park$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.